Accessibility Menu
iRhythm logo

iRhythm(NASDAQ) IRTC

Market Cap$3.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)+349%
5 Year+175%
1 Year-27%
1 Month+4%
$115.08
-1.57%
-1.84Today
After hours$115.28+$0.20 (+0.17%)
iRhythm last closing stock price
MetricPriceDate
Last closeUSD 115.242026-08-18
iRhythm stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.44%USD 121.872026-08-11
1 month+3.93%USD 110.882026-07-17
3 month-1.5%USD 117.002026-05-20
Year to date-35.05%USD 177.442025-12-31
1 year-27.03%USD 157.932025-08-18
3 year+4.72%USD 110.052023-08-18
5 year+174.97%USD 41.912021-08-19
Since inception+348.83%USD 26.052016-10-20

iRhythm Financials at a Glance

Market Cap

$3.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$825.34M

Net Income (TTM)

-$13.95M

EPS (TTM)

-$0.43

P/E Ratio

-265.04

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$115.08

Volume

570,576.598

Open

$116.97

Previous Close

$115.24

Daily Range

$114.95 - $120.34

52-Week Range

$100.85 - $212.00

Estimated Earnings Date

Oct 29, 2026

IRTC News

BuyAlert-Blue.png

This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund

Andy GouldMar 20, 2026
Foolcom-Featured.png

iRhythm (IRTC) Q2 Revenue Jumps 26%

Motley Fool Markets TeamAug 1, 2025
GettyImages-842292368

3 Med-Tech Stocks With Incredible Potential

Taylor CarmichaelMay 31, 2022
GettyImages-639817322

Missed Intuitive Surgical? Buy This Stock Instead

Patrick BafumaApr 20, 2022
Heart monitoring ECG

Why iRhythm Technologies Stock Skyrocketed Today

Keith SpeightsNov 3, 2021
three-invetors-looking-at-stocks

Here's Why iRhythm Technologies Stock Is Making Big Gains Today

Cory RenauerSep 13, 2021
healthcare-stock-falling-bear-market-medical-device-investing-CEO-resign

Why Did iRhythm Technologies Fall 16% in June?

Ryan DownieJul 6, 2021
Heart monitoring ECG

Why iRhythm Technologies Stock Is Crashing Today

Keith SpeightsApr 12, 2021
Page 1

IRTC: Motley Fool Moneyball Superscore

65

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About iRhythm

iRhythm Holdings, Inc. tracks heartbeats to find irregular rhythms. Patients wear a small patch that records their heart data. Computers in the cloud analyze this data for doctors.

Who Pays for Services?

  • Contracted Third-Party Payors: Insurance companies with pre-negotiated rates for monitoring services; accounts for 52% of revenue.
  • Centers for Medicare & Medicaid Services: Government-funded health coverage for elderly and disabled patients; represents 26% of revenue.
  • Healthcare Institutions: Direct sales of monitoring services to hospitals and private clinics; makes up 16% of revenue.
  • Non-Contracted Third-Party Payors: Insurance providers without formal pricing agreements; contributes 6% of revenue.

New Tech and New Deals

  • Acquired a technology license from BioIS on Aug. 30, 2024, to develop blood pressure and sleep apnea features.
  • Terminated a development partnership with Verily Life Sciences in August 2025.
  • Settled long-standing patent litigation with Baxter and its subsidiaries for $50 million on July 31, 2026.
  • Entered a definitive agreement on Aug. 5, 2026, to acquire VitalConnect for $237.5 million in cash and $50 million in stock.

What Makes the Tech Unique?

The company uses a cloud-based platform to curate over 3 billion hours of heartbeat data for medical reports. Operating through independent diagnostic testing facilities allows the firm to provide full-service monitoring directly to clinicians.

Performance by the Numbers

  • Net revenue rose 23% year over year to $423.6 million for the six-month period ended June 30, 2026.
  • Gross profit reached $304.6 million for the six-month period ended June 30, 2026, up 26% year over year.
  • Net loss was $14.3 million for the six-month period ended June 30, 2026, down 68% year over year.
  • Cash provided by operating activities was $24.9 million for the six-month period ended June 30, 2026.

Bottom Line

iRhythm has transitioned from a single-product provider to an integrated digital health platform with a clinical data set. The company is currently expanding its diagnostic reach through acquisitions and licenses for new biosensor technologies.

AI Generated • Aug 7, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

2,400

CEO

Quentin S. Blackford, CPA

Website

www.irhythmtech.com

Headquarters

San Francisco, CA 94103, US

IRTC Financials

Key Financial Metrics (TTM)

Gross Margin

71.45%

Operating Margin

-1.17%

Net Income Margin

-1.69%

Return on Equity

-8.97%

Return on Capital

-4.16%

Return on Assets

-1.28%

Earnings Yield

-0.38%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

32.96M

Volume

570.58K

Avg. Volume

612.12K

Financials (TTM)

Gross Profit

$589.74M

Operating Income

-$9.63M

EBITDA

$20.10M

Operating Cash Flow

$86.00M

Capital Expenditure

-$47.02M

Free Cash Flow

$38.98M

Cash & ST Invst.

$591.27M

Total Debt

$727.35M

iRhythm Performance Analysis

iRhythm annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 410,921,00027.3%
20232023-12-31USD 492,681,00019.9%
20242024-12-31USD 591,839,00020.1%
20252025-12-31USD 747,138,00026.2%
iRhythm sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-303.3%
Q42025-12-318.3%
Q12026-03-31-4.5%
Q22026-06-3012.4%
iRhythm annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -3.8812.4%
20232023-12-31USD -4.044.1%
20242024-12-31USD -3.63-10.2%
20252025-12-31USD -1.39-61.7%
iRhythm sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3063.6%
Q42025-12-31206.3%
Q12026-03-31-352.9%
Q22026-06-3097.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$224.17M

+20.1%

Gross Profit

$163.21M

+22.8%

Gross Margin

72.80%

N/A

Market Cap

$3.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.58M

N/A

Employees

2,400

N/A

Net Income

-$381.00K

+97.3%

EBITDA

$2.91M

+163.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$591.27M

+8.4%

Total Debt

$727.35M

-1.0%

Accounts Receivable

$84.27M

+2.6%

Inventory

$22.51M

+22.4%

Long Term Debt

$710.44M

-1.1%

Short Term Debt

$18.42M

+12.6%

Return on Assets

-1.28%

N/A

Return on Invested Capital

-1.07%

N/A

Free Cash Flow

$37.52M

+117.0%

Operating Cash Flow

$51.08M

+84.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CRSPCRISPR Therapeutics AG
$52.97-2.41%
RDNTRadNet, Inc.
$73.83-2.77%
TFXTeleflex Incorporated
$131.92-0.86%
BLCOBausch + Lomb Corporation
$17.04+0.24%

Trending Stocks

Symbol / CompanyPricePrice Chg
KORUDirexion Shares ETF Trust - Direxion Daily Msci South Korea Bull 3x Shares
$17.84-0.24%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$44.19+0.15%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$129.10-0.15%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$38.28+0.05%

Questions About IRTC

What is the current price of iRhythm?

iRhythm is trading at $115.24 per share.

What is the 52-week range for iRhythm?

Over the past 52 weeks, iRhythm has traded between $100.85 and $212.00.

How much debt does iRhythm have?

As of the most recent reporting period, iRhythm reported total debt of $727.35M.

How much cash does iRhythm have on hand?

iRhythm reported $246.68M in cash and cash equivalents in its most recent financial results.

What is iRhythm’s dividend yield?

iRhythm does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services